Moreover, there were significant differences regarding sub-staging in stage III CRC (p = 0.045) and formation of IVE (p = 0.008) between the FSTL3 high and low expression groups (Figure 1E). The gene discussed is FSTL3; the disease is colorectal carcinoma.